Cabot Corporation (NYSE:CBT) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Analysts give Cabot a consensus "Hold" rating (1 sell, 4 hold, 1 buy) with an average 12‑month price target of $73.75.
• Cabot beat on EPS ($1.53 vs. $1.40) but revenue fell 11.1% YoY to $849M, and management set FY2026 guidance at $6.00–$6.50 EPS
• Institutional investors own about 93.18% of the shares; the company has a market cap near $3.9B and a trailing P/E of ~13.1.

Shares of Cabot Corporation (NYSE:CBT - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $73.75.

A number of research analysts have recently commented on the company. Mizuho set a $75.00 price objective on Cabot and gave the company a "neutral" rating in a report on Wednesday, February 4th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Cabot in a report on Monday, December 29th. Jefferies Financial Group reiterated a "buy" rating and issued a $85.00 price objective on shares of Cabot in a report on Wednesday, February 4th. Zacks Research upgraded Cabot from a "strong sell" rating to a "hold" rating in a report on Tuesday, January 27th. Finally, UBS Group increased their price objective on Cabot from $74.00 to $81.00 and gave the company a "neutral" rating in a report on Thursday, February 5th.

Cabot Trading Down 2.2%

CBT opened at $74.70 on Friday. Cabot has a one year low of $58.33 and a one year high of $83.71. The company has a market cap of $3.90 billion, a P/E ratio of 13.08, a PEG ratio of 10.07 and a beta of 0.84. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. The business's 50-day simple moving average is $73.50 and its 200-day simple moving average is $70.10.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.13. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The business had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. During the same quarter in the prior year, the business posted $1.76 EPS. The business's revenue for the quarter was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, equities research analysts expect that Cabot will post 7.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio grew its stake in Cabot by 15.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company's stock worth $80,000 after buying an additional 160 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company's stock worth $417,000 after buying an additional 161 shares during the last quarter. Farther Finance Advisors LLC grew its stake in Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company's stock worth $124,000 after buying an additional 164 shares during the last quarter. Gabelli Funds LLC grew its stake in Cabot by 1.3% during the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company's stock worth $1,032,000 after buying an additional 180 shares during the last quarter. Finally, First Citizens Bank & Trust Co. grew its stake in Cabot by 1.4% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company's stock worth $1,107,000 after buying an additional 206 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.